Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Idiopathic Parkinson's disease (iPD) is a movement disorder characterized by the degeneration of dopaminergic neurons and aggregation of the protein α‐synuclein. Patients with iPD vary in age of symptom onset, rate of progression, severity of motor and non‐motor symptoms, and extent of central and peripheral inflammation. Genetic and environmental factors are believed to act synergistically in iPD pathogenesis. We propose that environmental factors (pesticides and infections) increase the risk for iPD via the immune system and that the role of PD risk genes in immune cells is worthy of investigation. This review highlights the major PD‐relevant genes expressed in immune cells and key environmental factors that activate immune cells and, alone or in combination with other factors, may contribute to iPD pathogenesis. By reviewing these interactions, we seek to enable the future development of immunomodulatory approaches to prevent or delay onset of iPD. © 2020 International Parkinson and Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Parkin and PINK1 mitigate STING-induced inflammation
Sliter, D. A., Martinez, J., Hao, L., Chen, X., Sun, N., Fischer, T. D., Burman, J. L., Li, Y., Zhang, Z., Narendra, D. P., et al. (2018) · Nature · doi:10.1038/s41586-018-0448-9 · Cited by 1,287 · cited 3×
“Acute and chronic in vivo mitochondrial stress was found to lead to a stimulator of interferon gene (STING)–meditated type I interferon response in mice in the absence of Parkin or PINK1.(76) Mitochondrial stress can lead to the release of DAMPs that can activate innate immunity, suggesting that mitophagy may mitigate…”
BackgroundInfluentialSelf-citationRetractedAssociation of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy
Lazarou, M., Sliter, D. A., Kane, L. A., Sarraf, S. A., Wang, C., Burman, J. L., Sideris, D. P., Fogel, A. I., & Youle, R. J. (2015) · Nature · doi:10.1038/nature14893 · Cited by 2,774 · cited 1×
“PINK1 is a kinase stabilized at the surface of damaged mitochondria where it phosphorylates both ubiquitin and Parkin, promoting the recruitment of mitophagy receptors to degrade dysfunctional mitochondria.(72,73) Importantly, in the absence of Parkin or PINK1, high levels of mitochondrial antigens are presented on MH…”
BackgroundGenome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Franke, A., McGovern, D. P. B., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., et al. (2010) · Nature Genetics · doi:10.1038/ng.717 · Cited by 2,520
Nalls, M. A., Blauwendraat, C., Vallerga, C. L., Heilbron, K., Bandres-Ciga, S., Chang, D., Tan, M., Kia, D. A., Noyce, A. J., Xue, A., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30320-5 · Cited by 2,454
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265
Parkinson's disease: a dual‐hit hypothesis
Hawkes, C. H., Del Tredici, K., & Braak, H. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00874.x · Cited by 1,021
Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974 · cited 1×
“Multiple studies report that the levels of α-synuclein in PD gut are higher than in the gut of non-PD controls.(15,18,19) in vitro and in vivo studies have suggested that microglia have the capacity to phagocytose certain species of α-synuclein as well as debris released by degenerating dopamine neurons.”
BackgroundDual microglia effects on blood brain barrier permeability induced by systemic inflammation
Haruwaka, K., Ikegami, A., Tachibana, Y., Ohno, N., Konishi, H., Hashimoto, A., Matsumoto, M., Kato, D., Ono, R., Kiyama, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13812-z · Cited by 923
Heo, J.-M., Ordureau, A., Paulo, J. A., Rinehart, J., & Harper, J. W. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.08.016 · Cited by 906
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866 · cited 1×
“In 2017, an initial report demonstrated that some T cells found in the peripheral blood mononuclear cell (PBMC) populations from iPD patients recognize α-synuclein-derived peptides.(26) Another study from the same group reported the presence of α-synuclein-specific T cells in PD patients and identified that T-cell inf…”
BackgroundA new pathway for mitochondrial quality control: Mitochondrial-derived vesicles
Sugiura, A., McLelland, G., Fon, E. A., & McBride, H. M. (2014) · The EMBO Journal · doi:10.15252/embj.201488104 · Cited by 862 · cited 1×
“Mitochondrial antigen presentation (MitAP) is driven by the formation of mitochondria-derived vesicles (MDVs), a quality control mechanism allowing the shuttle of specific mitochondrial cargos to late endosomes.(75) PINK1 and Parkin actively inhibit MDV formation and MitAP, providing a link between mitochondrial dynam…”
BackgroundBendor, J. T., Logan, T. P., & Edwards, R. H. (2013) · Neuron · doi:10.1016/j.neuron.2013.09.004 · Cited by 825
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
Houser, M. C., & Tansey, M. G. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-016-0002-0 · Cited by 588
Self-citationParkinson’s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation
Matheoud, D., Sugiura, A., Bellemare-Pelletier, A., Laplante, A., Rondeau, C., Chemali, M., Fazel, A., Bergeron, J. J., Trudeau, L.-E., Burelle, Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.039 · Cited by 582 · cited 1×
“Importantly, in the absence of Parkin or PINK1, high levels of mitochondrial antigens are presented on MHC class I molecules in both macrophages and dendritic cells by a vacuolar pathway distinct from mitophagy.(74) Mitochondrial antigen presentation (MitAP) is driven by the formation of mitochondria-derived vesicles…”
BackgroundIs alpha-synuclein in the colon a biomarker for premotor Parkinson’s disease? Evidence from 3 cases
Shannon, K. M., Keshavarzian, A., Dodiya, H. B., Jakate, S., & Kordower, J. H. (2012) · Movement Disorders · doi:10.1002/mds.25020 · Cited by 464 · cited 1×
“Multiple studies report that the levels of α-synuclein in PD gut are higher than in the gut of non-PD controls.(15,18,19) in vitro and in vivo studies have suggested that microglia have the capacity to phagocytose certain species of α-synuclein as well as debris released by degenerating dopamine neurons.”
BackgroundCroisier, E., Moran, L. B., Dexter, D. T., Pearce, R. K., & Graeber, M. B. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-14 · Cited by 414
Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., Cron, R. Q., Shacka, J. J., Raman, C., & Standaert, D. G. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5610-12.2013 · Cited by 406 · cited 19×
“We must be mindful of the context produced by genetic and environmental factors contributing to each patient’s risk of PD. Protection and risk may be conferred by an individual’s genes and exposures, and this will likely influence the immune system tone throughout the life span as well as responsiveness 32 Movement Di…”
BackgroundInfluentialα-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
Lindestam Arlehamn, C. S., Dhanwani, R., Pham, J., Kuan, R., Frazier, A., Rezende Dutra, J., Phillips, E., Mallal, S., Roederer, M., Marder, K. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15626-w · Cited by 386
Hui, K. Y., Fernandez-Hernandez, H., Hu, J., Schaffner, A., Pankratz, N., Hsu, N.-Y., Chuang, L.-S., Carmi, S., Villaverde, N., Li, X., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aai7795 · Cited by 384 · cited 1×
“The newly identified N2081D variant in the LRRK2 gene has been shown to be associated with increased risk for both CD and PD, whereas the N551K variant is associated with reduced risk for both diseases.(64) Studies in IBD mouse models based on dextran sulfate administration have been difficult to interpret, with the L…”
ResultGraef, I. A., Wang, F., Charron, F., Chen, L., Neilson, J., Tessier-Lavigne, M., & Crabtree, G. R. (2003) · Cell · doi:10.1016/s0092-8674(03)00390-8 · Cited by 379
The role of small intestinal bacterial overgrowth in Parkinson's disease
Fasano, A., Bove, F., Gabrielli, M., Petracca, M., Zocco, M. A., Ragazzoni, E., Barbaro, F., Piano, C., Fortuna, S., Tortora, A., et al. (2013) · Movement Disorders · doi:10.1002/mds.25522 · Cited by 344 · cited 1×
“pylori) seropositivity,(121) and a 2013 study reported a greater incidence of Helicobacter suis in gastric biopsies from iPD patients compared to healthy controls.(122) Another study in the same year, however, found no differences in the frequencies of H.”
ResultMHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
Cebrián, C., Zucca, F. A., Mauri, P., Steinbeck, J. A., Studer, L., Scherzer, C. R., Kanter, E., Budhu, S., Mandelbaum, J., Vonsattel, J. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4633 · Cited by 338 · cited 2×
“In response to exposure to microglia activated by α-synuclein, murine nigra dopamine neurons upregulate MHC class I, flagging themselves for cell killing mediated by antigen-specific CD8+ T cells.(25) If, as has been reported, human nigra neurons express MHC class I, it may be the case that α-synuclein can trigger a n…”
BackgroundLRRK2 levels in immune cells are increased in Parkinson’s disease
Cook, D. A., Kannarkat, G. T., Cintron, A. F., Butkovich, L. M., Fraser, K. B., Chang, J., Grigoryan, N., Factor, S. A., West, A. B., Boss, J. M., et al. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-017-0010-8 · Cited by 279 · cited 1×
“B cells and T cells from iPD patients have higher expression of LRRK2 than healthy controls, independent of any known LRRK2 variation or mutation.(50) CD16+ nonclassical monocytes, also called alternatively activated or patrolling monocytes, display higher LRRK2 expression in iPD patients than in controls as well.”
BackgroundSelf-citationZhang, W., Phillips, K., Wielgus, A. R., Liu, J., Albertini, A., Zucca, F. A., Faust, R., Qian, S. Y., Miller, D. S., Chignell, C. F., et al. (2011) · Neurotoxicity Research · doi:10.1007/s12640-009-9140-z · Cited by 257
Abrogation of α-synuclein–mediated dopaminergic neurodegeneration in LRRK2-deficient rats
Daher, J. P. L., Volpicelli-Daley, L. A., Blackburn, J. P., Moehle, M. S., & West, A. B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403215111 · Cited by 223 · cited 1×
“LRRK2-deficient microglia and macrogphages have dampened cytokine release after exposure to α-synuclein fibrils, whereas LRRK2 knockout rats exhibit reduced activated microglia after viral vector-mediated α-synuclein expression in the substantia nigra.(54,55) Furthermore, LRRK2-deficient cells more effectively interna…”
BackgroundSelf-citationMarinova‐Mutafchieva, L., Sadeghian, M., Broom, L., Davis, J. B., Medhurst, A. D., & Dexter, D. T. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06189.x · Cited by 217
Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region
Wissemann, W. T., Hill-Burns, E. M., Zabetian, C. P., Factor, S. A., Patsopoulos, N., Hoglund, B., Holcomb, C., Donahue, R. J., Thomson, G., Erlich, H., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.10.009 · Cited by 189
Krashia, P., Cordella, A., Nobili, A., La Barbera, L., Federici, M., Leuti, A., Campanelli, F., Natale, G., Marino, G., Calabrese, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11928-w · Cited by 188 · cited 1×
“Interestingly, rats overexpressing human α-synuclein display microglia activation and perturbations of inflammatory and proresolving mediators, namely IFN-γ and resolvin D1, in addition to neurodegeneration.(24) Innate immune cell activation and inflammation induced by α-synuclein could produce autoreactive T cells sp…”
BackgroundTreatment for Helicobacter pylori infection and risk of parkinson’s disease in Denmark
Nielsen, H. H., Qiu, J., Friis, S., Wermuth, L., & Ritz, B. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03643.x · Cited by 155
Takagawa, T., Kitani, A., Fuss, I., Levine, B., Brant, S. R., Peter, I., Tajima, M., Nakamura, S., & Strober, W. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8162 · Cited by 145 · cited 1×
“Studies in IBD mouse models based on dextran sulfate administration have been difficult to interpret, with the LRRK2 knockout initially more susceptible to damage with involvement of the Nuclear Factor of Activated T cells (NFAT) pathway,(39) and in more recent studies, the overexpression of LRRK2 was associated with…”
ResultEnteric alpha‐synuclein expression is increased in Parkinson's disease but not Alzheimer's disease
Gold, A., Turkalp, Z. T., & Munoz, D. G. (2013) · Movement Disorders · doi:10.1002/mds.25298 · Cited by 132 · cited 1×
“Multiple studies report that the levels of α-synuclein in PD gut are higher than in the gut of non-PD controls.(15,18,19) in vitro and in vivo studies have suggested that microglia have the capacity to phagocytose certain species of α-synuclein as well as debris released by degenerating dopamine neurons.”
BackgroundNuzum, N. D., Loughman, A., Szymlek-Gay, E. A., Hendy, A., Teo, W.-P., & Macpherson, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.003 · Cited by 103 · cited 1×
“In some populations, exposure to tuberculosis itself increases the risk for iPD.(119) Beyond infection, the activity of gastrointestinal microbes is increasingly being investigated in relation to PD pathology.”
BackgroundIncreased peripheral inflammation in asymptomatic leucine‐rich repeat kinase 2 mutation carriers
Dzamko, N., Rowe, D. B., & Halliday, G. M. (2016) · Movement Disorders · doi:10.1002/mds.26529 · Cited by 98
Lrrk2 alleles modulate inflammation during microbial infection of mice in a sex-dependent manner
Shutinoski, B., Hakimi, M., Harmsen, I. E., Lunn, M., Rocha, J., Lengacher, N., Zhou, Y. Y., Khan, J., Nguyen, A., Hake-Volling, Q., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aas9292 · Cited by 96 · cited 1×
“typhimurium and reovirus infection in a sexdependent manner, with females exhibiting impaired ability to control infection.(63) These studies suggest LRRK2 expression changes in response to infection; however, future studies are needed to explore this relationship in humans as most of these studies have been conducted…”
ResultBantle, C. M., Phillips, A. T., Smeyne, R. J., Rocha, S. M., Olson, K. E., & Tjalkens, R. B. (2019) · npj Parkinson's Disease · doi:10.1038/s41531-019-0090-8 · Cited by 89 · cited 1×
“In 80% of people who survived EL, secondary parkinsonism was later described,(113) although, as with influenza and EL, no clear causal factor has been identified, and the association is contested by some.(114) Nonetheless, it has been reported that individuals who were young at the time of the Spanish flu pandemic and…”
BackgroundKumaran, R., & Cookson, M. R. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv236 · Cited by 86 · cited 1×
“In mouse splenocytes or rat thymic cells, deltamethrin induces apoptosis.(102,106) Cypermethrin has been shown to decrease plasma IL-2, IL-8, IL-12, and IFN-γ.”
BackgroundParkinsonism: siblings share Helicobacter pylori seropositivity and facets of syndrome
Charlett, A., Dobbs, R. J., Dobbs, S. M., Weller, C., Brady, P., & Peterson, D. W. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb00654.x · Cited by 82
Helicobacter pylori eradication for Parkinson's disease
Rees, K., Stowe, R., Patel, S., Ives, N., Breen, K., Clarke, C. E., & Ben-Shlomo, Y. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008453.pub2 · Cited by 56
Cited by
Inflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
Self-citationThe microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Tan, A. H., Lim, S. Y., & Lang, A. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00681-2 · Cited by 392
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Blesa, J., Foffani, G., Dehay, B., Bezard, E., & Obeso, J. A. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00542-9 · Cited by 232
Liu, Z., Fan, Q., Wu, S., Wan, Y., & Lei, Y. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01462-4 · Cited by 112
“The levels of neutrophils, monocytes, and lymphocytes, which are white blood cells (WBCs) found in circulating blood, increase when there is peripheral inflammation and participate in the development of clinical symptoms in PD patients [2, 8, 9].”
BackgroundUpregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease
Kasen, A., Houck, C., Burmeister, A. R., Sha, Q., Brundin, L., & Brundin, P. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105654 · Cited by 78
Metadata
- Authors
- Kline, E. M., Houser, M. C., Herrick, M. K., Seibler, P., Klein, C., West, A., & Tansey, M. G.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2020-12-14
- Volume
- 36
- Issue
- 1
- Pages
- 25-36
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W3112561953
- Cited by
- 130
- References
- 40
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.